We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRAI icon
3376
CRA International
CRAI
$1.07B
$225K ﹤0.01%
+1,839
New +$203K
EAD
3377
Allspring Income Opportunities Fund
EAD
$377M
$225K ﹤0.01%
35,157
+8,326
+31% +$54.1K
IRTC icon
3378
iRhythm Holdings
IRTC
$4.06B
$225K ﹤0.01%
2,398
-337
-12% -$36.7K
NU icon
3379
Nu Holdings
NU
$67.3B
$224K ﹤0.01%
55,104
+1,554
+3% +$6.75K
AIR icon
3380
AAR Corp
AIR
$5.77B
$224K ﹤0.01%
+4,984
New +$217K
LNC icon
3381
CALL
Lincoln National
LNC
$8.67B
$224K ﹤0.01%
+69,700
New +$2.77M
PXF icon
3382
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.98B
$224K ﹤0.01%
5,383
-3,365
-38% -$133K
THFF icon
3383
First Financial Corp
THFF
$975M
$224K ﹤0.01%
4,852
-451
-9% -$21.3K
MVT
3384
DELISTED
BlackRock MuniVest Fund II
MVT
$223K ﹤0.01%
21,387
-27,268
-56% -$280K
LGND icon
3385
Ligand Pharmaceuticals
LGND
$5.76B
$223K ﹤0.01%
3,344
-2,053
-38% -$133K
CBH
3386
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$223K ﹤0.01%
25,834
GGME icon
3387
Invesco Next Gen Media and Gaming ETF
GGME
$46.9M
$223K ﹤0.01%
6,949
ZIMV
3388
DELISTED
ZimVie
ZIMV
$223K ﹤0.01%
23,840
+12,731
+115% +$111K
UHT
3389
Universal Health Realty Income Trust
UHT
$573M
$222K ﹤0.01%
4,660
-135
-3% -$6.51K
RRBI icon
3390
Red River Bancshares
RRBI
$681M
$222K ﹤0.01%
4,355
+210
+5% +$11.4K
EVX icon
3391
VanEck Environmental Services ETF
EVX
$102M
$222K ﹤0.01%
8,140
SNEX icon
3392
StoneX
SNEX
$8.05B
$220K ﹤0.01%
+11,705
New +$217K
PLCE icon
3393
Children's Place
PLCE
$53.4M
$220K ﹤0.01%
+6,042
New +$226K
SHCR
3394
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$220K ﹤0.01%
137,400
-55,272
-29% -$102K
PENG
3395
Penguin Solutions Inc
PENG
$3.12B
$220K ﹤0.01%
14,758
-18,413
-56% -$282K
KRNT icon
3396
Kornit Digital
KRNT
$827M
$220K ﹤0.01%
+9,558
New +$239K
NPK icon
3397
National Presto Industries
NPK
$987M
$219K ﹤0.01%
3,201
-128
-4% -$8.75K
DDIV icon
3398
First Trust Exchange-Traded Fund VI First Trust Dorsey Wright Momentum & Dividend ETF
DDIV
$80.8M
$219K ﹤0.01%
+7,657
New +$223K
RING icon
3399
iShares MSCI Global Gold Miners ETF
RING
$2.4B
$219K ﹤0.01%
9,799
-1,379
-12% -$28.4K
ACHV icon
3400
Achieve Life Sciences
ACHV
$744M
$219K ﹤0.01%
89,249
+71,818
+412% +$184K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.